EvokAI Creative Labs Inc.

EvokAI Creative Labs Inc.

OKAI · V · Healthcare / Health Information Services

0.115CAD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.115
Open0.115
Day Range0.115 – 0.115
52-Week Range0.115 – 0.115
Volume0
Market Cap874.63K
P/E (TTM)0.00
Forward P/E0.00
EPS-2.18
Dividend Yield0.00%
Beta-1.24
50-Day Avg0.115
200-Day Avg0.115

About

EvokAI Creative Labs Inc., a MedTech artificial-intelligence (AI)-powered company, engages in the development of transformational technologies for the healthcare sector. The company's artificial intelligence-enhanced diagnostic profiles provide a basis to monitor mental wellbeing and enable advances in medical diagnoses. It deploys machine learning models to search medical data, integrate novel medical devices, and uncover insights to help improve health outcomes, patient experiences, drug development, preclinical and clinical decisions, and provide accurate diagnoses. The company also provides EvokAI Simulators, which combine cognitive neuroscience, virtual reality (VR), and AI technologies to assess cognitive performance and spatial perception; EvokAI Movement Disorder Monitor (MDM) Basic, a wireless and real-time monitor that accurately analyzes the magnitude of movement disorders and the effectiveness of treatments for Parkinson´s disease and other movement disorders, such as dystonia, various diseases causing tremors, Tourette´s syndrome, congenial CP, or MS; and EvokAI MDM PRO, which is used to monitor movement disorders in real time for the accurate surgical results. In addition, it offers EvokAI Neurotrainer, which provides brain health solutions for various ages; and EvokAI Medical, which offers mental wellbeing through AI-driven digital solutions. The company is headquartered in Vancouver, Canada. EvokAI Creative Labs Inc. is a subsidiary of Union Acquisition Group, LLC.

Company Details

  • SectorHealthcare
  • IndustryHealth Information Services
  • CEOMr. Alejandro Antalich
  • Employees0
  • Headquarters609 Granville Street, Vancouver, BC, Canada, V7Y 1C3, Canada
  • Websitehttps://www.evokailabs.com

Leadership

  • Mr. Alejandro AntalichCEO & Director · b. 1974
  • Mr. Scott Edwin AckermanCFO, Corporate Secretary & Director · b. 1967
  • Mr. Rauno JokelainenOperations Manager
  • Dr. Georg MeissnerExecutive Vice President of Digital Health Research & Technology
  • Ms. Tuula PalmenChief Business Officer
  • Mr. Hans J. LauterbachPresident of Europe, Asia Pacific & Middle East

Financials

Income Statement

Currency: USD2021-12-312022-12-312023-12-31
Total Revenue000
Operating Income-86.08K-715.38K-2.34M
EBITDA-86.08K-715.38K-17.07M
Net Income-86.08K-715.38K-17.08M
R&D-413.52K352.36K
Interest Expense-017.68K

Balance Sheet

Currency: USD2021-12-312022-12-312023-12-31
Total Assets55.34K4.06K873.70K
Total Liabilities0664.22K1.16M
Total Equity55.34K-660.15K-284.34K
Cash5.34K4.06K774.49K
Net Debt-41.46K12.58K

Cash Flow

Currency: USD2021-12-312022-12-312023-12-31
Operating Cash Flow-89.69K-1.17K-2.53M
Financing Cash Flow00-109.41K
Capital Expenditure000
Free Cash Flow-89.69K-1.17K-2.53M
FCF to OCF100.00%100.00%100.00%

Earnings

Report DateSep 28, 2026Oct 5, 2026
EPS Estimate--
EPS Actual--
Surprise--
TimingAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap874.63K
Enterprise Value2.01M
Trailing P/E0.00
Forward P/E0.00
Price / Sales714.86
Price / Book0.00
EPS-2.18
Book Value-0.1782
Revenue (TTM)12.77K
Gross Profit (TTM)0
Profit Margin0.00%
Operating Margin0.00%
Return on Equity-231.26%
Return on Assets-13.44%
Shares Outstanding7.61M
Shares Float3.50M
Beta-1.24
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Feb 5, 20251:10
  • Apr 14, 2023375:1000
  • Apr 25, 201721:100